
Results
5
High Growth Stocks
5 companies
Zevra Therapeutics
Market Cap: US$673.4m
A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.
ZVRA
US$11.44
7D
8.6%
1Y
21.3%
Arcutis Biotherapeutics
Market Cap: US$3.3b
A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.
ARQT
US$26.28
7D
-3.0%
1Y
68.1%
Kiniksa Pharmaceuticals International
Market Cap: US$6.1b
A biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally.
KNSA
US$78.15
7D
0.09%
1Y
132.2%
BeOne Medicines
Market Cap: US$40.8b
An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.
ONC
US$359.05
7D
9.6%
1Y
16.8%
Sotera Health
Market Cap: US$5.5b
Provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.
SHC
US$18.89
7D
5.1%
1Y
20.2%